Peptide questions · Efinopegdutide

How long does efinopegdutide take to work?

Reviewed Evidence: ModeratePublished by PepVault

Efinopegdutide’s onset is weeks, its peak effect comes at 24–52 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 2b MASH (Lawitz 2026, Lancet; NCT05877547), phase 2a vs semaglutide (Romero-Gómez 2023, J Hepatol), phase 2 obesity (Alba 2021, Clin Obes), development history (Hope 2021, Front Endocrinol). Investigational.

Efinopegdutide week by week

The library places five of its research notes on efinopegdutide on the days they cover, from day 1 to day 364: 5 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The efinopegdutide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)A gentle first monthRandomized trial
Days 29–364 (weeks 5–52)Four milligramsRandomized trial
Days 57–364 (weeks 9–52)The dose the trial favouredRandomized trial
Days 57–364 (weeks 9–52)Weight comes down tooRandomized trial
Days 85–364 (weeks 13–52)Ten milligrams: more side effects, not more benefitRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track efinopegdutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The efinopegdutide timeline’s milestones

The library’s timeline for efinopegdutide marks 4 points from week 1 to week 52, backed by moderate evidence overall.

  • Week 1: Commonly reported: appetite dropping in the first days on 2 mg
  • Week 4: The MASH trial stepped up every 4 weeks: 2, 4, 7, then 10 mg
  • Week 24: Phase 2a: liver fat down about 73% at 10 mg vs 42% on semaglutide 1 mg
  • Week 52: Phase 2b: liver inflammation resolved in 56% to 63% vs 13% on placebo

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why efinopegdutide takes that long

The library states no half-life with a number for efinopegdutide (it says: “Not reported in an open human PK source; dosed once weekly in all its trials”), so this page can’t work out a build-up; the timing rests on the notes above.

The notes on efinopegdutide follow the trials’ dose steps, 2mg, 4mg, 7mg and 10mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Efinopegdutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, efinopegdutide among them; none of the others shares its onset of weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does efinopegdutide take to work?

Efinopegdutide’s onset is weeks, its peak effect comes at 24–52 weeks (trial endpoints), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does efinopegdutide reach its peak effect?

By the library’s timeline, efinopegdutide’s peak effect comes at 24–52 weeks (trial endpoints), backed by moderate evidence.

How long is efinopegdutide usually run?

The library’s timeline gives efinopegdutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 24 to 52 weeks, stepping up every 4 weeks from 2 mg in the MASH trial.

What does the library say about the first days on efinopegdutide?

Its first note on efinopegdutide, for days 1–28 (weeks 1–4), is “A gentle first month”, resting on randomized trials.

More on efinopegdutide

Track it in the app

PepVault for iPhone

Track efinopegdutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo